Botox tested as a remedy for facial flushing
NCT ID NCT02216838
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study investigates whether injections of botulinum toxin A (Botox) can treat persistent facial flushing. In a split-face design, each participant receives Botox on one side of the face and a saline placebo on the other, allowing direct comparison. The trial enrolls 16 adults aged 18 to 65 with ongoing facial flushing and measures changes using a spectrophotometer. As a pilot study, it aims to see if this approach is worth studying further.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- botulinum toxin A (Botox)
- What this could lead to
- If effective, Botox could offer a new option for people bothered by persistent facial redness.
- What could go wrong
- This is a very small pilot study with only 16 people, so results may not apply broadly. Botox injections carry risks like bruising or temporary muscle weakness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIAL FLUSHING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago, Illinois, 60611, United States